ONE Snare® Endovascular Snare System Microsnare Sizes Receive FDA 510(k) Approval

I'm pleased to announce that ONE Snare microsnare sizes are FDA 510(k) cleared and available for sale in the United States.

These new ONE Snare product configurations are available in loop diameters of 2 mm, 4 mm and 7 mm with a 2.3F-3F snare delivery catheter. The ONE Snare suite of endovascular snares are now available in fifteen kit configurations with ten loop diameters ranging from 2 mm to 35 mm. These sizes complete the suite of ONE Snare product configurations and give physicians additional choice and options when foreign body manipulation or retrieval procedures arise.

Designed with accuracy and reliability in mind, the ONE Snare and the EN Snare® Endovascular Snare Systems go hand-in-hand to provide physicians with both single loop and triple loop options to help meet any clinically-challenging case that may arise, because having options matters.

To learn more, visit the ONE Snare product webpage.

Jesse Hansen
Marketing Director

Scion Clo-Sur P.A.D. to be included in Companion to Braunwald’s Heart Disease Textbook

Merit Medical was recently notified that an illustration featuring the Scion Clo-Sur P.A.D will be included in Cardiovascular Intervention: A Companion to Braunwald's Heart Disease, first edition by Deepak L. Bhatt MD. The book's publication date is May 2015. Braunwald's Heart Disease is a textbook of cardiovascular medicine. It is updated frequently to include the latest clinical trials, new research, and updates on clinical practice for practitioners, physicians-in-training, and students of cardiology. The author, Deepak L. Bhatt MD, MPH, FACC, FAHA, FSCAI, FESC is a Professor of Medicine, Harvard Medical School and Executive Director, Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart & Vascular Center, in Boston, Massachusetts. He has authored or co-authored over 700 publications. Dr. Bhatt is the Editor of the peer-reviewed Journal of Invasive Cardiology, Chief Medical Editor of Cardiology Today’s Intervention for healthcare professionals, and Editor-in-Chief of the Harvard Heart Letter for patients.

The Clo-Sur P.A.D. is a non-woven topical pad made with a proprietary polyprolate, a positively-charged material that reacts with negatively-charged red blood cells to accelerate clotting. The Clo-Sur P.A.D. promotes hemostasis and the Clo-Sur PLUS P.A.D.™ promotes hemostasis and is indicated as an antimicrobial barrier.

The book's illustration depicts how the Clo-Sur P.A.D.'s positive charge which reacts with negatively charged red blood cells to accelerate clotting in the tissue tract.



To learn more about the Clo-Sur P.A.D., watch the product video or Contact Us.

Mark Heninger
Senior Product Manager

What to Expect After a Uterine Fibroid Embolization

What to Expect After a Uterine Fibroid Embolization

For women considering uterine fibroid embolization to treat uterine fibroid tumors, it is important to understand what to expect after your procedure.
UFE is a less invasive procedure done by an Interventional Radiologist (IR). The doctor will make one small incision in the groin area. From there, he or she inserts a small tube and uses X-ray equipment to guide it through the arteries in the leg and uterus.
Once the radiologist reaches the fibroids, he or she will inject small embolization particles into the arteries providing blood and oxygen the fibroids.
Without oxygen, the fibroid cannot stay alive so the tumors will shrink.  The embolization particles will remain in the uterus to prevent fibroid tumors from coming back.
The treatment lasts less than one hour. It is considered an outpatient procedure, meaning you will be able to go home that day and will not spend the night. You will not be fully sedated so you will remain awake throughout the experience.  However, a prescription painkiller will be given to you to help ease any pain your fibroid tumors may be causing you.
Patients should not plan on driving themselves home after the procedure is complete.  Pain medications given during or after your fibroid treatment will not allow you to safely drive yourself home.  Plan on bringing someone with you or having someone pick you up once you have been released.
What happens after UFE?
After the UFE procedure, you may experience pain in the lower stomach area.  You can expect to feel slight cramping like the pain you feel during your period.  However, your doctor will prescribe medications to help ease any discomfort.
Your comfort is extremely important to your doctor and nurses.  Expect to stay anywhere from 4 to 23 hours after your procedure is complete.  Your stay will be determined by how you are feeling after your uterine fibroid treatment.
Once the Interventional Radiologist (IR) feels that you are ready to go home, he or she will give you discharge instructions.  These instructions will have everything you need to know about post-UFE care. They will also include directions about medications you will need to take.
Your discharge instructions will direct you on when you can expect to return to normal activities. It will have a list of phone numbers you may call with any questions about your post-UFE care plan.
What kind of follow-up should I expect?
After your procedure is complete, your IR will consult with your OB-GYN for any follow up.  Be sure to ask your IR about when to expect follow-up appointments. Typical timeframes for these appointments are one week post-procedure and three months post-procedure.
How can I expect to feel once I am home?
At home, you may continue to have pain similar to menstrual cramps.  Cramping can last a few days after the procedure. Your doctor will have given you directions for managing this type of pain. Generally, you will receive medications for pain management.
3367489083_c3f61b9276_z.jpg
If you experience fever symptoms after your treatment, check your discharge plan for any directions about medications you can take to reduce fever.  You want to be sure to not take anything that may react with the pain medications you have been given. If you have questions about symptoms or a fever medication that is safe to take, call your doctor.
Some patients suffer nausea due to the pain medications.  Medications can and should be changed immediately if you feel extreme nausea.
Some patients may experience “post-embolization syndrome,” which may include flu-like symptoms such as a low fever, a vague feeling of discomfort, and mild nausea.  These symptoms can occur within a few hours or up to a few days after UFE.
Most women are able to return to light activity within just a few days of UFE. You should be able to return to work and a normal level of activity within 11 days of treatment.

To find a physician in your area who can perform the UFE procedure, use the Find a Physician tool at ask4ufe.com.



This content is not intended nor recommended as a substitute for medical advice, diagnosis or treatment. Always seek the advice of a qualified physician regarding any medical questions or conditions.

ONE Snare® Endovascular Snare System Microsnare Sizes Approved for Sale in Europe

I'm pleased to announce that ONE Snare microsnare sizes are CE marked and available for sale in Europe.

These new ONE Snare product configurations are available in loop diameters of 2 mm, 4 mm and 7 mm with a 2.3F-3F snare delivery catheter. The ONE Snare suite of endovascular snares are now available in fifteen kit configurations with ten loop diameters ranging from 2 mm to 35 mm. These sizes complete the suite of ONE Snare product configurations and give physicians additional choice and options when foreign body manipulation or retrieval procedures arise.

Designed with accuracy and reliability in mind, the ONE Snare and the EN Snare® Endovascular Snare Systems go hand-in-hand to provide physicians with both single loop and triple loop options to help meet any clinically-challenging case that may arise, because having options matters.

To learn more, visit the ONE Snare product webpage.

Jesse Hansen
Marketing Director, Interventional

Merit Medical Exhibiting at 2014 VEITH Symposium in New York on November 18-22

Merit Medical is proud to support the VEITH Symposium, celebrating its 41st year, in New York City. Attendees for this meeting include vascular surgeons, interventional radiologists, interventional cardiologists and other vascular specialists.

If you plan to attend VEITH, please make sure to stop by our booth to learn more about our latest innovations from access to intervention. Some of these unique devices include:
From preparation to intervention, our products are designed to help achieve the clinical, economical, and procedural efficiency that is essential for delivering the best possible care.

Look forward to seeing you at VEITH!

Jesse Hansen
Marketing Director